19.89

0.30% 0.06

After Hours: 19.91 0.02 +0.10%

Entrada Therapeutics Inc (TRDA)

Overview News Price History Financials Discussions Forecast

Entrada Therapeutics Inc stock is traded at $19.89, with a volume of 75,845. It is up +0.30% in the last 24 hours and up +15.10% over the past month. Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Previous Close:

$19.83

Open:

$19.83

24h Volume:

75,845

Relative Volume:

0.58

Market Cap:

$744.28M

Revenue:

$239.40M

Net Income/Loss:

$104.44M

P/E Ratio:

-7.7093

EPS:

-2.58

Net Cash Flow:

$-18.50M

1W Performance:

+5.80%

1M Performance:

+15.10%

6M Performance:

+29.24%

1Y Performance:

+52.76%

1-Day Range:

$19.52

$20.02

1-Week Range:

$18.81

$20.02

52-Week Range:

$11.35

$20.49

Entrada Therapeutics Inc Stock (TRDA) Company Profile

Name

Entrada Therapeutics Inc

Sector

Healthcare (1180)

Industry

Biotechnology (675)

Phone

857-305-1825

Address

ONE DESIGN CENTER PLACE, BOSTON

Employee

177

Twitter

Next Earnings Date

2024-08-12

Latest SEC Filings

TRDA's Discussions on Twitter

Compare TRDA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TRDA Entrada Therapeutics Inc	19.89	744.28M	239.40M	104.44M	-18.50M	2.96
VRTX Vertex Pharmaceuticals Inc	468.13	120.56B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	750.22	82.44B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	616.55	36.87B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	253.07	32.64B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	118.39	28.38B	3.30B	-501.07M	1.03B	-2.1146

Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-24	Initiated	Oppenheimer	Outperform
Apr-03-23	Initiated	H.C. Wainwright	Buy

Entrada Therapeutics Inc Stock (TRDA) Latest News

Nov 28, 2024

Massachusetts Financial Services Co. MA Invests $1.11 Million in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 28, 2024

Nov 26, 2024

(TRDA) Investment Analysis and Advice - Stock Traders Daily

Nov 26, 2024

Connor Clark & Lunn Investment Management Ltd. Has $2.22 Million Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 26, 2024

Nov 25, 2024

Entrada Therapeutics (TRDA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Nov 25, 2024

Nov 17, 2024

Los Angeles Capital Management LLC Makes New $542,000 Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Insider Sale at Entrada Therapeutics Inc (TRDA) by President of Research & Development - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

500: Something went wrong - Investing.com UK

Nov 13, 2024

Entrada Therapeutics stock hits 52-week high at $20.28 By Investing.com - Investing.com Canada

Nov 13, 2024

Nov 11, 2024